AbbVie (ABBV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, AbbVie (ABBV) reported revenue of $15.78 billion, up 9.1% over the same period last year. EPS came in at $1.86, compared to $3.00 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $15.59 billion, representing a surprise of +1.2%. The company delivered an EPS surprise of +5.08%, with the consensus EPS estimate being $1.77.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...